Tomiki Sumiyoshi Selected Research

Serotonin 5-HT1 Receptor Agonists

10/2013	Neural basis for the ability of atypical antipsychotic drugs to improve cognition in schizophrenia.
9/2007	Effect of buspirone, a serotonin1A partial agonist, on cognitive function in schizophrenia: a randomized, double-blind, placebo-controlled study.
3/2006	Perospirone in the treatment of schizophrenia: effect on verbal memory organization.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Tomiki Sumiyoshi Research Topics

Disease

69	Schizophrenia (Dementia Praecox) 11/2022 - 12/2002
14	Psychotic Disorders (Schizoaffective Disorder) 01/2021 - 01/2003
12	Cognitive Dysfunction 01/2021 - 10/2008
10	Mental Disorders (Mental Disorder) 11/2022 - 08/2008
5	Mood Disorders (Mood Disorder) 12/2021 - 07/2003
2	Neurobehavioral Manifestations 01/2022 - 10/2008
2	Major Depressive Disorder (Major Depressive Disorders) 01/2022 - 06/2018
2	Alzheimer Disease (Alzheimer's Disease) 07/2019 - 05/2012
2	Dementia (Dementias) 07/2019 - 01/2012
2	Progressive Myoclonic Epilepsies (Progressive Myoclonic Epilepsy) 05/2018 - 01/2018
2	Shock 01/2014 - 06/2006
2	Diabetes Mellitus 08/2004 - 06/2004
1	Motor Skills Disorders (Motor Skills Disorder) 06/2022
1	Bipolar Disorder (Manic Depressive Psychosis) 01/2020
1	Tourette Syndrome (Tourette's Syndrome) 01/2020
1	Tics (Tic) 01/2020
1	Hallucinations (Hallucination) 10/2019
1	Central Nervous System Diseases (CNS Diseases) 03/2018
1	Seizures (Absence Seizure) 01/2017
1	Neuromyelitis Optica (Devic's Disease) 01/2017
1	Psychomotor Agitation (Akathisia) 01/2017
1	Tetralogy of Fallot (Fallot Tetralogy) 01/2017
1	Neurodevelopmental Disorders 05/2014
1	Genetic Predisposition to Disease (Genetic Predisposition) 01/2014

Drug/Important Bio-Agent (IBA)

28	Antipsychotic Agents (Antipsychotics)IBA 04/2021 - 01/2003
8	tandospironeIBA 02/2022 - 06/2006
6	Olanzapine (Zyprexa)FDA Link 05/2018 - 06/2004
6	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 01/2018 - 03/2004
6	Clozapine (Clozaril)FDA LinkGeneric 01/2017 - 06/2004
6	Serotonin (5 Hydroxytryptamine)IBA 01/2015 - 10/2008
6	N-Methylaspartate (NMDA)IBA 05/2014 - 03/2004
5	Risperidone (Risperdal Consta)FDA LinkGeneric 01/2020 - 06/2004
5	perospironeIBA 04/2013 - 03/2006
4	Biomarkers (Surrogate Marker)IBA 01/2020 - 09/2006
4	Lactic Acid (Lactate)FDA LinkGeneric 01/2014 - 06/2006
4	Dopamine (Intropin)FDA LinkGeneric 01/2014 - 07/2004
4	Dizocilpine Maleate (Dizocilpine)IBA 01/2014 - 09/2010
3	Antidepressive Agents (Antidepressants)IBA 01/2022 - 06/2018
3	Biological ProductsIBA 01/2021 - 01/2010
3	Pharmaceutical PreparationsIBA 01/2020 - 09/2006
3	ParvalbuminsIBA 01/2018 - 05/2012
3	Quetiapine Fumarate (Seroquel)FDA Link 01/2018 - 06/2004
3	Fatty Acids (Saturated Fatty Acids)IBA 12/2017 - 01/2008
3	blonanserinIBA 01/2017 - 01/2012
3	1-(3-(2-(1-benzothiophen-5-yl) ethoxy) propyl)-3-azetidinol maleateIBA 01/2015 - 01/2012
3	Serotonin 5-HT1 Receptor AgonistsIBA 10/2013 - 03/2006
3	5-HT1A Serotonin ReceptorIBA 09/2012 - 12/2008
3	ziprasidone (Geodon)FDA Link 09/2012 - 12/2006
2	Buspirone (Buspar)FDA LinkGeneric 01/2020 - 09/2007
2	Aripiprazole (Abilify)FDA Link 01/2020 - 12/2008
2	salicylhydroxamic acid (SHAM)IBA 07/2019 - 01/2017
2	Methamphetamine (Desoxyn)FDA LinkGeneric 01/2016 - 07/2004
2	gamma-Aminobutyric Acid (GABA)IBA 01/2015 - 10/2013
2	Aminobutyrates (Aminobutyric Acid)IBA 01/2015 - 05/2012
2	Serotonin ReceptorsIBA 01/2014 - 10/2008
2	Dopamine Receptors (Dopamine Receptor)IBA 01/2014 - 09/2006
2	maleic acid (maleate)IBA 05/2012 - 01/2012
2	Neuroprotective AgentsIBA 05/2012 - 01/2012
2	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 03/2011 - 01/2008
2	Phospholipids (Phosphatides)FDA LinkGeneric 03/2011 - 01/2008
2	Phencyclidine (Angel Dust)IBA 09/2010 - 09/2006
2	Psychotropic Drugs (Psychoactive Drugs)IBA 11/2008 - 08/2008
2	Glutamate Receptors (Glutamate Receptor)IBA 09/2005 - 03/2004
2	Amino Acids FDA Link 09/2005 - 03/2004
2	Glycine (Aminoacetic Acid)FDA LinkGeneric 09/2005 - 03/2004
2	Serine (L-Serine)FDA Link 09/2005 - 03/2004
2	metylperon (melperone)IBA 07/2003 - 01/2003
1	dicarboxydine (DCD)IBA 06/2022
1	acetovanillone (apocynin)IBA 02/2022
1	Dopamine Agents (Dopaminergic Agents)IBA 02/2022
1	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 01/2022
1	propylene diquat (PDQ(+))IBA 01/2022
1	ORALIT (ORS)IBA 10/2019
1	Modafinil (Provigil)FDA Link 01/2019
1	Hemoglobins (Hemoglobin)IBA 01/2018
1	Polytetrafluoroethylene (Teflon)FDA Link 01/2018
1	Paliperidone Palmitate FDA Link 12/2017
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 12/2017
1	Anticonvulsants (Antiepileptic Drugs)IBA 01/2017
1	Topiramate (Topamax)FDA LinkGeneric 01/2017
1	Valproic Acid (Depakote)FDA LinkGeneric 01/2017
1	Trazodone (Trittico)FDA LinkGeneric 01/2017
1	DNA (Deoxyribonucleic Acid)IBA 01/2016
1	Messenger RNA (mRNA)IBA 01/2016
1	metabotropic glutamate receptor 3 (mGluR3)IBA 05/2014
1	D-Aspartic Acid (D Aspartate)IBA 01/2014
1	Nootropic Agents (Nootropics)IBA 01/2014
1	CatecholaminesIBA 01/2014
1	EnzymesIBA 01/2014
1	MethyltransferasesIBA 01/2014
1	Glutamic Acid (Glutamate)FDA Link 10/2013
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 12/2008
1	Cholinergic Agents (Cholinergics)IBA 12/2008

Therapy/Procedure

12	Transcranial Direct Current Stimulation 11/2022 - 01/2017
7	Therapeutics 11/2019 - 10/2008
4	Electrodes (Electrode) 01/2022 - 01/2013
3	Cognitive Training 01/2019 - 07/2009
2	Drug Therapy (Chemotherapy) 01/2015 - 06/2012
1	Transcranial Magnetic Stimulation 11/2022
1	Drug Tapering 01/2018